摘要
由于大自然作为新药候选来源的重要性,本文的目的是强调海洋天然产品,这些产品具有抗结核活性,发表在Ja之间。2000年和2016年5月,从海洋资源获得的250种化合物的138份引文。这些代谢产物由化学成分组成,被命名为简单的烷基脂衍生物aro。衍生物,肽,生物碱,萜类,甾体,大环内酯和多环多酮类化合物。
关键词: 抗结核,海洋天然产品,结核分枝杆菌,海洋药物,抗菌,天然产品衍生物。
Current Medicinal Chemistry
Title:Antitubercular Marine Natural Products
Volume: 25 Issue: 20
关键词: 抗结核,海洋天然产品,结核分枝杆菌,海洋药物,抗菌,天然产品衍生物。
摘要: Due to the importance of nature as a source of new drug candidates, the purpose of this article is to emphasize the marine natural products, which exhibit antitubercular activity, published between January 2000 and May 2016, with 138 quotations to 250 compounds obtained from marine resources. These metabolites are organized by chemical constitution and named as simple alkyl lipids derivatives, aromatics derivatives, peptides, alkaloids, terpenoids, steroids, macrolides, and polycyclic polyketides.
Export Options
About this article
Cite this article as:
Antitubercular Marine Natural Products, Current Medicinal Chemistry 2018; 25 (20) . https://dx.doi.org/10.2174/0929867324666170113120221
DOI https://dx.doi.org/10.2174/0929867324666170113120221 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mycobacterium w Immunotherapy for Treating Pulmonary Tuberculosis - a Systematic Review
Current Pharmaceutical Design Inhaled Formulation Design for the Treatment of Lung Infections
Current Pharmaceutical Design Use of Anti-Infective Drugs in Rheumatology
Anti-Infective Agents in Medicinal Chemistry Agave (Agave spp.) and its Traditional Products as a Source of Bioactive Compounds
Current Bioactive Compounds Simultaneously Determining Seven Second-Line Anti-TB Drugs by UHPLC- MS: Application for TDM in HIV-TB Patients
Current Pharmaceutical Analysis Development and Optimization of Dual Drugs (Isoniazid and Moxiflox-acin) Loaded Functional PLGA Nanoparticles for the Synergistic Treatment of Tuberculosis
Current Drug Delivery Selection of Microbial T-Cell Epitopes for Immune-Diagnosis, Immune- Therapy and Vaccine Design
Current Pharmacogenomics Oral Agents in Multiple Sclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Key Amino Acids of Arabidopsis VKOR in the Activity of Phylloquinone Reduction and Disulfide Bond Formation
Protein & Peptide Letters From Bone Marrow Transplantation to Cellular Therapies: Possible Therapeutic Strategies in Managing Autoimmune Disorders
Current Pharmaceutical Design Vitamin D, Sunlight and Cancer Connection
Anti-Cancer Agents in Medicinal Chemistry Immunogenicity and Therapeutic Effects of pVAX1-rv1419 DNA from Mycobacterium tuberculosis
Current Gene Therapy A Review of the Treatment of Psoriasis with Infliximab
Reviews on Recent Clinical Trials Similarities/Dissimilarities Analysis of Protein Sequences Based on Recurrence Quantification Analysis
Current Bioinformatics Expression, Purification, Crystallization and Preliminary X-Ray Crystallographic Analysis of the Resuscitation Promoting Factor Interacting Protein RipA from M. tuberculosis
Protein & Peptide Letters Reverse Vaccinology: An Epitope Based Approach to Design Vaccines
Current Bioinformatics Systems Biology of Apoptosis and Survival: Implications for Drug Development
Current Pharmaceutical Design Pneumonia in Lung Transplant Recipients
Current Respiratory Medicine Reviews Autophagy: For Better or for Worse, in Good Times or in Bad Times …
Current Molecular Medicine Enzymes with Phosphotriesterase and Lactonase Activities in Archaea
Current Chemical Biology